Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8 Remdesivir Intermediate COVID-19
Manufacturer Commercial Supple Remdesivir et intermedia cum High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl((S)-(perfluorophenoxys)(phosphoryl)-L-alaninatum CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolitae (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermedia CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Nomen chemicum | Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine |
Synonyma | 4-Aminopyrrolo[2,1-f][1,2,4]triazine;Remdesivir medium |
CAS Number | 159326-68-8 |
CATTUS Number | RF-PI302 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C6H6N4 |
M. Pondus | 134.14 |
Density | 1.50 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-Pulvis alba |
Infrared Imaginis | Conformat ut Structure |
Puritas | ≥99.0% |
Damnum in Siccatio | ≤0.50% |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Metalla gravis | ≤20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Remdesiviri (CAS 1809249-37-3) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabricae et elit Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine (CAS 159326-68-8) magna qualitate.Hoc est medium Remdesivir (CAS 1809249-37-3).Remdesivir est latum-spectrum antiviralis prodrug quod ostendit actionem antiviralem contra SARS coronavirus, MERS coronavirus et recentius Covid-19.Remdesivir (GS-5734), nucleoside analogum cum efficaci antivirali actione, habet EC50s 74 nm pro SARS-CoV et MERS-CoV in cellulis HAE, et 30 nm pro hepatitis murini in cellulis tumoris cerebri morati.Remdesivir plurimum valet in potestate SARS-CoV-2 (COVID-19) infectio in vitro.